Epstein Barr Virus (EBV) Reactivation After Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplantation.

被引：0
|
作者：
Peric, Zinaida [1 ]
Cahu, Xavier [1 ]
Chevallier, Patrice [1 ]
Brissot, Eolia [1 ]
Malard, Florent [1 ]
Guillaume, Thierry [1 ]
Delaunay, Jacques [1 ]
Ayari, Sameh [1 ]
Dubruille, Viviane [1 ]
Le Gouill, Steven [1 ]
Mahe, Beatrice [1 ]
Gastinne, Thomas [1 ]
Blin, Nicolas [1 ]
Saulquin, Beatrice [1 ]
Harrouseau, Jean-Luc [2 ]
Moreau, Philippe [1 ]
Milpied, Noel [3 ]
Coste-Burel, Marianne [4 ]
Imbert-Marcille, Berthe-Marie [4 ]
Mohty, Mohamad [1 ]
机构：
[1] CHU Nantes, Dept Hematol, F-44035 Nantes 01, France
[2] Ctr Reg Lutte Canc CRLCC Rene Gauducheau, St Herblain, France
[3] CHU Bordeaux, Dept Hematol, Bordeaux, France
[4] CHU Nantes, Virol Lab, F-44035 Nantes 01, France
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：539 / 540
页数：2
相关论文
共 50 条
  • [11] Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem cell transplantation
    Ahmad, Imran
    Kwan, John
    Meuleman, Nathalie
    Lewalle, Philippe
    Crokaert, Francoise
    Bron, Dominique
    BLOOD, 2007, 110 (11) : 328B - 328B
  • [12] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR HEMATOLOGIC MALIGNANCIES AFTER REDUCED INTENSITY CONDITIONING (RIC) IN CHILDREN AND YOUNG ADULTS
    Duerst, R. E.
    Jacobsohn, D. A.
    Tse, W.
    Schneiderman, J.
    Kletzel, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 78 - 78
  • [13] Study of recombinant erythropoietin after reduced intensity conditioning (RIC) for allogeneic stem cell transplantation (ASCT)
    Blaise, D
    Ivanov, V
    Faucher, C
    Ladaique, P
    Bilger, K
    Mohty, M
    Sainty, D
    Chabannon, C
    Vey, V
    Maraninchi, D
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 221 - 221
  • [14] Monitoring of Epstein–Barr virus load in patients after allogeneic hematopoietic stem cell transplantation
    P. Volfova
    M. Lengerova
    J. Winterova
    Z. Racil
    D. Dvorakova
    J. Mayer
    Infection, 2012, 40 : 583 - 587
  • [15] Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation
    Xiu-li Wu
    Qi-fa Liu
    Journal of Hematology & Oncology, 5 (Suppl 1)
  • [16] No Evidence of Impact of Maraviroc on Outcome after Allogeneic Hematopoietic Stem Cell Transplant with Reduced Intensity Conditioning (RIC)
    Hammond, William Adam
    Heckman, Michael
    Finn, Laura
    Diehl, Nancy N.
    Shreders, Amanda
    Flowers, Patricia
    Roy, Vivek
    Foran, James
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S396 - S397
  • [17] Epstein–Barr virus reactivation after allogeneic stem cell transplantation without lymph node enlargement
    William H. Krüger
    Frank Schüler
    Christian Lotze
    Günther Schwesinger
    Renate Mentel
    Christoph Busemann
    Gottfried Dölken
    Annals of Hematology, 2005, 84 : 477 - 478
  • [18] Validation of Comorbidity Indexes in Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation. the Hematopoietic Cell Transplantation Comorbidity Index Is the Best Predictor of NRM and Survival
    Barba, Pere
    Pinana, Jose Luis
    Amoros, Alex
    Valcarcel, David
    Martino, Rodrigo
    Sureda, Anna
    Briones, Javier
    Delgado, Julio
    Granell, Miquel
    Brunet, Salut
    Sunol, Ma Rosa
    Sierra, J.
    BLOOD, 2008, 112 (11) : 1125 - 1125
  • [19] Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation
    Ahmad, Imran
    Cau, Nguyen V.
    Kwan, John
    Maaroufi, Younes
    Meuleman, Nathalie
    Aoun, Mickael
    Lewalle, Philippe
    Martiat, Philippe
    Crokaert, Francoise
    Bron, Dominique
    TRANSPLANTATION, 2009, 87 (08) : 1240 - 1245
  • [20] Management of Epstein-Barr virus reactivation following allogeneic stem cell transplantation
    Lankester, Arjan C.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2007, 12 (03) : 163 - 165
12345